Presentation examples for Resources and Costs

The Lean LaunchPad

07/27/12

Life Science Intellectual Property Example

CanScanIntellectual Property

Does Harvard own it?

Does Harvard want it?

Does Berkeley want it?

Does Berkeley own it?

Will they license it

to us?

Will they license it

to us?

Proceed with patent filing

and pre-clinical trials

Extreme Pivot

Y

N

Y

N N

N

Y

Y

N N

Y Y

Class 7 - Update 3.12.2012

Meeting with Berkeley Technology Transfer at LBNL (This Week)Meeting with Harvard Technology Office (Next Week)

Robotic AgricultureResource, Activities Example

We’ve hit our first milestones

Jun 2011 Dec 2011 Jun 2012Mar 2013First unit

Seed Round

Confidential

Technology Track

Customer Discovery Track

Finance Track

Post-processed Image recognition

Prototype First unit

Series A

Customer trial and customer order

Real-time image recognition

Select 1st target crop

Friends and family round

Applied for grants

Testing agreement with top producer

$125 KF&F

$800 KSeed

$3-5 MSeries A

Medical DeviceResource, Activities & Cost Example

$10M

$15M

2012

Series A $3.5 MM

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Initialize

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016

Series B $9 MM

System

2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

Launch

Series C $30.5 MM

$30M

$20M

Regulatory / Clinical

Series D $35

MM

M&A / IPO $50 MM

$40M

7 12/4/2009

Proof of Concep

t

Pilot Studie

s

IC and Processing Patents

Marketable Product

Provisional Patent

Beta-Versio

n Testin

g

Application and

System Patents

IRB / IDE

Clinical Results

Second Release

Initial Product Launch

Specific Codes (Cat. I CPT / APC)

Non-Specific Codes

1st Release

Test

2nd Release Test

Publication

Post-Market Clinical Studies

Beta Prototype

US Interim Trials

FDA – Class II – 510 (k) with Clinical Trials

Publication

Financial / Operations Timeline

Cat III

CPT

US Pivotal Clinical Trials

Laboratory

Prototype

Technology

Licensing

MammOpticsMammOptics

Financial timeline

$10M

$15M

2012

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Initialize

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016 2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

$30M

$20M

$40M

8 12/4/2009

Proof of Concep

t

Provisional Patent

Financial / Operations Timeline

Technology

Licensing

MammOpticsMammOptics

$10M

$15M

2012

Series A $3.5 MM

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Initialize

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016

System

2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

$30M

$20M

$40M

9 12/4/2009

Proof of Concep

t

Provisional Patent

Beta-Versio

n Testin

g

Laboratory

Prototype

Beta Prototype

Technology

Licensing

Financial / Operations Timeline

Pilot Studie

s

MammOpticsMammOptics

$10M

$15M

2012

Series A $3.5 MM

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016

Series B $9 MM

System

2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

$30M

$20M

$40M

10 12/4/2009

IC and Processing Patents

Marketable Product

Beta-Versio

n Testin

g

Application and

System Patents

IRB / IDE

Beta Prototype

Financial / Operations Timeline

Pilot Studie

s

Regulatory / Clinical

Laboratory

Prototype

MammOpticsMammOptics

$10M

$15M

2012

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016

Series B $9 MM

System

2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

Series C $30.5 MM

$30M

$20M

Regulatory / Clinical

$40M

11

IC and Processing Patents

Application and

System Patents

IRB / IDE

Cat III

CPT

Second Release

1st Release

Test

US Interim Trials US Pivotal Clinical Trials

Publication

Financial / Operations Timeline

Pilot Studie

s

MammOpticsMammOptics

$10M

$15M

2012

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016 2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

Launch

Series C $30.5 MM

$30M

$20M

Regulatory / Clinical

Series D $35

MM

$40M

12 12/4/2009

Clinical Results

Second Release

Initial Product Launch

Non-Specific Codes

2nd Release Test

Publication

US Interim Trials

FDA – Class II – 510 (k) with Clinical Trials

Publication

Financial / Operations Timeline

US Pivotal Clinical Trials

MammOpticsMammOptics

$10M

$15M

2012

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016 2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

Launch

$30M

$20M

Regulatory / Clinical

Series D $35

MM

M&A / IPO $50 MM

$40M

12/4/2009

Clinical Results

Initial Product Launch

Specific Codes (Cat. I CPT / APC)

Non-Specific Codes

Publication

Post-Market Clinical Studies

FDA – Class II – 510 (k) with Clinical Trials

Financial / Operations TimelineMammOpticsMammOptics

$10M

$15M

2012

Series A $3.5 MM

Cash

Rese

rve

Clin

ical

Mile

stones

$5M

Initialize

Desi

gn

Mile

stones

Reg

ula

tory

/ IP

M

ilest

ones

Q1 Q2 Q3 Q4

2013Q1 Q2 Q3 Q4

2014Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016

Series B $9 MM

System

2017Q1 Q2Q1 Q2 Q3 Q4

2018Q3

Launch

Series C $30.5 MM

$30M

$20M

Regulatory / Clinical

Series D $35

MM

M&A / IPO $50 MM

$40M

14 12/4/2009

Proof of Concep

t

Pilot Studie

s

IC and Processing Patents

Marketable Product

Provisional Patent

Beta-Versio

n Testin

g

Application and

System Patents

IRB / IDE

Clinical Results

Second Release

Initial Product Launch

Specific Codes (Cat. I CPT / APC)

Non-Specific Codes

1st Release

Test

2nd Release Test

Publication

Post-Market Clinical Studies

Beta Prototype

US Interim Trials

FDA – Class II – 510 (k) with Clinical Trials

Publication

Financial / Operations Timeline

Cat III

CPT

US Pivotal Clinical Trials

Laboratory

Prototype

Technology

Licensing

MammOpticsMammOptics

AppleResource, Activities & Cost Example

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

Product User Digital Hub Digital Lifestyle Digital Platform

Invest in R&D

solutions for differentiated customers -

professional & consumer

High-end mass market

software developers

online store

brand - Apple,

PowerMac, iMac

component makers, shipping

& logistic suppliers

build whole devices both

h/w & s/w

differentiated markets

Computers, software & services

audio-visual content

producers & record labels

iPod, iTunes software &

content agreements

purchase & mgmt of digital music,

audio, video

increase switching costs

iTunes store

control the supply chain

increased investment

in R&D

iPod, music & related products

Integrated phone, games &

apps across devices

reduce cost of sales

increase switching costs -

integrationoptimize supply chain

content agreements - games & apps

iTunes through wi-fi

access

app & game developers &

cellular operators

app & game developers

iPhone, apps & related services

book publishers & developers of digital content

content agreements with book publishers

all digital devices linked through

software platform

increased switching costs -

shared information

iTunes bookstore

iPad, apps, books & related services

book publishers & developers of digital content

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

Product User Digital Hub Digital Lifestyle Digital Platform

Invest in R&D

solutions for differentiated customers -

professional & consumer

High-end mass market

software developers

online store

brand - Apple,

PowerMac, iMac

component makers, shipping

& logistic suppliers

build whole devices both

h/w & s/w

differentiated markets

Computers, software & services

audio-visual content

producers & record labels

iPod, iTunes software &

content agreements

purchase & mgmt of digital music,

audio, video

increase switching costs

iTunes store

control the supply chain

increased investment

in R&D

iPod, music & related products

Integrated phone, games &

apps across devices

reduce cost of sales

increase switching costs -

integrationoptimize supply chain

content agreements - games & apps

iTunes through wi-fi

access

app & game developers &

cellular operators

app & game developers

iPhone, apps & related services

book publishers & developers of digital content

content agreements with book publishers

all digital devices linked through

software platform

increased switching costs -

shared information

iTunes bookstore

iPad, apps, books & related services

book publishers & developers of digital content

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

solutions for differentiated customers -

professional & consumer

High-end mass market

software developers

Wholesalers, retailers, re-

sellers

online store

brand - Apple,

PowerMac, iMac

innovative designers

IP & patents & agreement

s

component makers

Shipping & logistic

suppliers

build whole devices both

h/w & s/w

software developers

differentiated markets

Invest in R&D

Computers, software & services

Product User

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

audio-visual content

producers

recordlabels

iPod, iTunes software &

content agreements

retail stores

purchase & mgmt of digital music, audio,

video

integration of information

across devices

control buying

experience

increase switching

costs

iTunes store

chain of owned stores

control the supply chain

increased investment

in R&D

iPod, music & related products

Product User Digital Hub

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

games & apps across devices

easy access & purchase

through iTunes

reduce cost of sales

increase switching costs -

integration

specialized services in retail stores

optimize supply chain

integrated phone

iPhone

content agreements extended to

games & apps

iTunes through wi-fi

access

app & game developers

app & game developers

cellular network

operators

iPhone, apps & related services

Product User Digital Hub Digital Lifestyle

KEYRESOURCES

VALUEPROPOSITON

DISTRIBUTION CHANNELS

CUSTOMER RELATIONSHIPS

CUSTOMERSEGMENTS

REVENUE STREAMSCOST STRUCTURE

KEYACTIVITIES

PARTNERNETWORK

Product User Digital Hub Digital Lifestyle

content agreements with book publishers

Digital Platform

all digital devices linked through

software platform

Premium re-sellers

book publishers

3rd party developers of

digital content

developers of

digital content

book publishers

premium resellers

control customer

experience in resellers’ stores

increased switching costs -

shared information

iPad & related services

iTunes bookstore

iPad, apps, books & related services